clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00529373 |
P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
P582 | end time | 2012-11-01 | |
P1050 | medical condition | osteoporosis | Q165328 |
P2899 | minimum age | 65 | |
P1132 | number of participants | 16713 | |
P4844 | research intervention | (5R)-24,25-Dihydroxyvitamin D | Q27161510 |
calcium oxalate | Q412399 | ||
P580 | start time | 2007-09-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium |
Search more.